Low Daily Dose of Aspirin Shown to Reduce Risk of Bowel Cancer
Thursday 16 September 2010
Mark Flannagan, CEO of Beating Bowel Cancer comments on encouraging findings published today which indicate that taking a low daily dose of aspirin for just one year can reduce a healthy person’s risk of developing bowel cancer by 22%, rising to 30% risk reduction after 5 years


